Correlation Between Sonnet Biotherapeutics and Avenue Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Avenue Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Avenue Therapeutics.

Diversification Opportunities for Sonnet Biotherapeutics and Avenue Therapeutics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sonnet and Avenue is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Avenue Therapeutics

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Avenue Therapeutics. In addition to that, Sonnet Biotherapeutics is 1.29 times more volatile than Avenue Therapeutics. It trades about -0.57 of its total potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.2 per unit of volatility. If you would invest  240.00  in Avenue Therapeutics on August 31, 2024 and sell it today you would lose (34.00) from holding Avenue Therapeutics or give up 14.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  Avenue Therapeutics

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Avenue Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Sonnet Biotherapeutics and Avenue Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and Avenue Therapeutics

The main advantage of trading using opposite Sonnet Biotherapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.
The idea behind Sonnet Biotherapeutics Holdings and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals